hexamethonium has been researched along with Recrudescence in 2 studies
Hexamethonium: A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Saunders, PR | 1 |
Miceli, P | 1 |
Vallance, BA | 1 |
Wang, L | 1 |
Pinto, S | 1 |
Tougas, G | 1 |
Kamath, M | 1 |
Jacobson, K | 1 |
Murthy, S | 1 |
Dinoso, VP | 1 |
Natrajan, R | 1 |
2 other studies available for hexamethonium and Recrudescence
Article | Year |
---|---|
Noradrenergic and cholinergic neural pathways mediate stress-induced reactivation of colitis in the rat.
Topics: Acute Disease; Animals; Atropine; Autonomic Pathways; Bretylium Tosylate; CD3 Complex; Colitis; Colo | 2006 |
Neurohormonal mechanisms of cigarette smoke-induced duodenal mucosal bicarbonate secretion in the rat.
Topics: Animals; Atropine; Bicarbonates; Brunner Glands; Duodenal Ulcer; Duodenum; Gastrointestinal Hormones | 1997 |